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interventions are hampered by the lack of speciﬁc and easily detectable
markers. We described a regulatory pathway in which nuclear migra-
tion of protein kinase C α controls the release of pri-miRNA15a. After
endothelin-1 stimulation the migration of PKCα is inhibited, and
mature miRNA15a is made. Using qRT-PCR we detect miRNA15a in the
urine of adult and pediatric patients with membranous or minimal
change nephropathy. By laser-microdissection this miRNA is predom-
inantly located in the proximal tubules. In cell culture, human RPTECs
produce the highest miRNA15a levels after ET-1 stimulation. In rats
after 5/6 nephrectomy, miRNA15a is increased in the urine. By graded
sieving and qRT-PCR, the highest amount of miRNA15a is found in the
tubular fraction. Selegiline treatment upregulates PKCα in vitro and
in the murine adriamycin model, signiﬁcantly downregulating ET-1
induced miRNA15a production. Thus measuring urinary miRNA15a
levels: i) indicates the regulation of a signal pathway in RPTECs in vivo
in proteinuric conditions; ii) allows for the ﬁrst time to control the
effectiveness of a therapy aiming to protect proximal tubules.
doi:10.1016/j.lfs.2013.12.204
ET-B receptors in podocytes promote diabetic glomerulosclerosis
with β-catenin and NFκB activation
Olivia Lenoira,b, Marine Milona,b, Anne Virsolvyc,
Yuri Kotelevtsevd,e, Masashi Yanagisawaf, David J. Webbd,
Sylvain Richardc, Pierre-Louis Tharauxa,b,g
aParis Cardiovascular Research Centre — PARCC, Institut National de la
Sante et de la Recherche Medicale (INSERM), Paris, France
bUniversite Paris Descartes, Sorbonne Paris Cite, Paris, France
cINSERM, CHU A. de Villeneuve, Montpellier, France
dUniversity of Edinburgh, The Queen's Medical Research Institute,
Edinburgh, UK
ePushchino State Institute for Natural Sciences, 142290, Russian Federation
fUniversity of Texas Southwestern Medical Center, Dallas, TX, USA
gService de Nephrologie, Hopital Europeen Georges Pompidou,
Assistance Publique Hopitaux de Paris, Paris, France
E-mail address: olivia.lenoir@inserm.fr (O. Lenoir)
Recently the endothelin (ET) system has emerged as a novel target
for the treatment of diabetic nephropathy (DN) with anti-proteinuric
actions. However, no evidence for a direct in vivo pathogenic effect of
ET-1 on podocytes has been shown. Despite podocyte dysfunction in
DN, speciﬁc ET-1 signaling in podocytes has not been investigated. This
study investigated ET signaling in podocytes during experimental DN.
We ﬁrst demonstrated that the prominent functional ET-1 receptors
eliciting rapid calcium transients in podocytes are ETBRs. Mice with a
podocyte-speciﬁc double deletion of ETAR and ETBR (Pod-ETRKO)were
rendered diabetic by streptozotocin injection. Whereas wild-type
diabetic mice developed mild DN with microalbuminuria, mesangial
matrix expansion and podocyte loss, Pod-ETRKO mice were protected
from diabetes induced glomerulosclerosis and podocyte loss. We next
found that total β-catenin and phospho- NFκB expressions are strongly
reduced in glomeruli from Pod-ETRKO mice. Moreover, ET-1 could
directly activate β-catenin and NFκB signaling pathways in freshly
isolated glomeruli. This is the ﬁrst evidence that ET-1 activation drives
development of glomerulosclerosis and podocyte loss through direct
activation of ETRs in podocytes, and likely, through NFκB and β-catenin
pathways. Surprisingly, both at the expression level and the functional
level, the ETBR subtype was found to be prominent. Furthermore, these
results indicate that activation of the ET-1 pathways selectively in
podocytes is involved in pathophysiological crosstalk that inﬂuences
mesangial architecture and sclerosis.
doi:10.1016/j.lfs.2013.12.205
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Urinary ET-1 (UET-1) excretion may result from cellular exposure
to shear stress but the relative contributions of renal blood ﬂow
and tubular ﬂow are not known. We measured changes in UET-1 in
response to changes in renal perfusion pressure (RPP) in the rat
in order to identify associations between UET-1, urinary ﬂow rate
(UV), urinary sodium excretion rate (UNaV) and RPP. Methods:
Seven male Sprague Dawley rats weighing 258 ± 17 g underwent
induced pressure natriuresis. Arterial blood pressure was measured
directly and urine was collected via tube cystotomy. RPP was initially
increased by ligation of both the coeliac and cranial mesenteric arteries
and subsequently of the distal aorta. Glomerular ﬁltration rate (GFR)
and effective renal plasma ﬂow (ERPF) were determined by FITC-
inulin and para- aminohippurate clearance, respectively. UET-1 was
measured by a sandwich ELISA assay (Biomedica). Urinary sodium
was measured by sodium-selective electrode analysis. Results: GFR
and ERPF did not change signiﬁcantly when RPP increased from
137 ± 9 to 162 ± 11 mmHg but signiﬁcant increases in UV (4 ± 1 to
97 ± 33 μl/min/g kw) and UNaV (1 ± 1 to 23 ± 9 μmol/min/g kw)
had linear relationships with RPP (r2 = 0.39, p = 0.022 and r2 =
0.51, p b0.001 respectively). UET-1 increased from 11 ± 7 to 42 ±
26 fg/min/g kw (p = 0.014) but was not predicted by RPP. UET-1
did, however, strongly correlate with UV (r = 0.69, p = 0.001) and
UNaV (r = 0.65, p = 0.002). Conclusions: In the rat, UET-1 is more
associated with renal tubular ﬂow than renal blood ﬂow at higher RPPs.
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